Malte Peters

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Julie Fogarty, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Malte Peters:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. President & CEO, Director Common Stock 367,500 $3,256,050 $8.86 08 Jan 2026 Direct
HOOKIPA Pharma Inc. Chief Executive Officer, Director Common Stock 54,347 $44,656 $0.8217 19 Aug 2025 Direct
Tango Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 1,650,000 08 Jan 2026 Direct

Insider Reports Filed by Malte Peters

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 08 Jan 2026 2 $0 4 President & CEO, Director 12 Jan 2026, 06:15
TNGX Tango Therapeutics, Inc. 03 Nov 2025 1 $0 4 Director 04 Nov 2025, 09:25
HOOK HOOKIPA Pharma Inc. 19 Aug 2025 1 -$20,684 4 Chief Executive Officer, Director 09 Oct 2025, 16:22
HOOK HOOKIPA Pharma Inc. 22 Jul 2025 1 -$26,842 4 Chief Executive Officer, Director 23 Jul 2025, 18:09
TNGX Tango Therapeutics, Inc. 05 Jun 2025 2 $0 4 Director 09 Jun 2025, 17:51
HOOK HOOKIPA Pharma Inc. 22 Jul 2024 1 $0 4 Chief Executive Officer, Director 24 Jul 2024, 16:17
HOOK HOOKIPA Pharma Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:15
TNGX Tango Therapeutics, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 17:21
HOOK HOOKIPA Pharma Inc. 09 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:16
TNGX Tango Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 21:33
HOOK HOOKIPA Pharma Inc. 01 Jan 2023 0 $0 3 Director 18 Apr 2023, 19:42
TNGX Tango Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:29
TNGX Tango Therapeutics, Inc. 10 Aug 2021 0 $0 3 Director 12 Aug 2021, 20:37